Home
Search
BIO International Convention   |   June 16-19, 2025

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Martin Crook
VICE PRESIDENT OF CORPORATE DEVELOPMENT ASSESSMENTS, BRISTOL MYERS SQUIBB
Bristol Myers Squibb
Kyriea Crudup
ALUMNA, MOREHOUSE SCHOOL OF MEDICINE
Creating Higher Educational Pipelines in Biotechnology that Addresses Diversity, Equity, and Inclusion
Marisa Cruz, MD
CHIEF MEDICAL OFFICER, EMPATICA
Advancing Digital Health Innovation in the Gray Space of Evolving FDA Regulations: What to Expect in 2023 and Beyond
Jasmin Cui, PhD
CEO AND CO-FOUNDER, INNOCARE
Forging Biotech Alliances in China
Kevin Curran, PhD
SCIENTIFIC ADVISOR AND INSTRUCTOR, BIOTECH PRIMER
Introduction to Cell Therapy
Michael Curran, PhD
THE UT MD ANDERSON CANCER CENTER ASSOCIATE PROFESSOR, DEPT. OF IMMUNOLOGY, CO-FOUNDER, ORBIT PLATFORM
The Future of Combination Therapies for Cancer Treatment
Michael Curry
PRESIDENT & CEO, MASSACHUSETTS LEAGUE OF COMMUNITY HEALTH CENTERS, MA HEALTH EQUITY COMPACT FOUNDER
The Power of Community-Based Partnerships: Advancing Health Equity to Eliminate Disparities in Access to Care
Jie D'Elia
SENIOR VICE PRESIDENT, BUSINESS DEVELOPMENT, ONCOLOGY, HEMATOLOGY & CELL THERAPY, BRISTOL MYERS SQUIBB
In today’s disruptive health care environment, how will biotech transform?
Placeholder Photo
Paul Dabrowski
CEO, SYNTHEGO CORPORATION
Synthego Corporation
Redwood City, California, United States
Placeholder Photo
Steven Damon, PhD
CEO, MICRON BIOMEDICAL, INC.
Micron Biomedical
Atlanta, Georgia, United States